B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PTPN1

MOLECULAR TARGET

protein tyrosine phosphatase non-receptor type 1

UniProt: P18031NCBI Gene: 577015 compounds

PTPN1 (protein tyrosine phosphatase non-receptor type 1) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PTPN1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Oleanolic Acid4.0154
2Ursolic Acid3.5835
3celastrol2.5612
4Okadaic Acid1.614
5caffeic acid0.691
6Chlorogenic Acid0.691
7Methylene Blue0.691
8Oleic Acid0.691
9Mepentol [Supplementary Concept]0.691
10Evans Blue0.691
11Lithocholic Acid0.691
12Palmitic Acid0.691
13prunetin0.691
14Suramin0.691
15vanadates0.691

About PTPN1 as a Drug Target

PTPN1 (protein tyrosine phosphatase non-receptor type 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented PTPN1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PTPN1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.